Molecular determinants of platelet delta storage pool deficiencies: an update

Area of Science:

• Hematology
• Platelet Biology
• Genetics

Background:

• Delta storage pool deficiency (δ-SPD) is a rare platelet disorder characterized by reduced dense granules.
• This condition leads to mild to moderate mucocutaneous bleeding, with current management focused on preventing excessive blood loss.
• Recent research using mouse models and related congenital diseases has shed light on the pathophysiology of δ-SPD.

Purpose of the Study:

• To review recent findings on the molecular mechanisms and clinical features of δ-SPD.
• To highlight δ-SPD as a group of disorders affecting intracellular vesicle biogenesis and trafficking.
• To discuss the potential of next-generation sequencing for identifying causative genes and developing targeted therapies.

Main Methods:

• Review of current literature on δ-SPD, Hermansky-Pudlak syndrome, and Chediak-Higashi syndrome.
• Analysis of insights gained from mouse models of platelet dense granule deficiency.
• Discussion of next-generation sequencing strategies for genetic diagnosis.

Main Results:

• δ-SPD is a genetically heterogeneous group of disorders affecting intracellular vesicle pathways.
• Understanding the pathophysiology is advancing through studies of related congenital diseases and animal models.
• The molecular basis of isolated inherited δ-SPD is still largely unknown.

Conclusions:

• δ-SPD represents a spectrum of intracellular vesicle biogenesis and trafficking defects.
• Identifying causative genes through next-generation sequencing is crucial for diagnosis and therapy development.
• Future research holds promise for novel therapeutic strategies for δ-SPD.